FDA inspection

BrightGene Fine Chemical Co., Ltd: FDA inspection ending May 31, 2019

FDA inspection 1095515 · Voluntary Action Indicated (VAI) · Taizhou

Key facts

Inspection ID 1095515
Firm BrightGene Fine Chemical Co., Ltd
FEI number 3011254184
Address No. 22 Bin Jiang South Rd, Taixing
City Taizhou
Fiscal year 2019
Inspection end date May 31, 2019
Classification Voluntary Action Indicated (VAI)
Project area New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections